top of page

Board of Directors

Headshot.jpg

DAN ADAMS, JD

Chairman, EpiVax Therapeutics

ADG - Headshot.jpg

ANNE (ANNIE) DE GROOT, MD

Co-Founder, CEO & CSO @ EpiVax

Bill_edited.jpg

WILLIAM MARTIN, BA

Co-Founder, COO & CIO @ EpiVax

RL headshot_edited.png

RICHARD LIPKIN, MBA

Managing Director @ Easton Capital
Co-founder of The Catalytic Impact Foundation

Rachel-Butler_200x200.png

RACHEL BUTLER
President @ The Catalytic Impact Foundation

ADVISORS

bridon.jpg

Peptide technology expert with over 35 years of experience

M. Cox.jpg

MANON COX, PHD, MBA

CEO, NextWaveBio

Scientific and strategic direction

Amy-Rosenberg_edited.jpg

AMY ROSENBERG, MD

Senior Director, EpiVax

Former Division Director, CDER, FDA

Regulatory veteran

J.Lieberman.webp

JUDY LIEBERMAN, MD, PHD

Professor & Chair Immunology, Harvard Medical School

Accomplished immunology expert

E.Ramos.jpg

ELENAOR RAMOS, MD

CMO/COO, Provention Bio

Clinical development and medical affairs specialist

Chemistry Class

PARTNERS

NYU-Langone.jpg

NYU LANGONE HEALTH

U.Chicago.png

UNIVERSITY OF CHICAGO

MountSinai_IcahnSchool_Logo.jpg

MOUNT SINAI

SGI.jpg

SYNTHETIC GENOMICS

Brown.jfif

BROWN UNIVERSITY

ITI.png

IMMUNOMIC THERAPEUTICS

Polypeptide.jpg

POLYPEPTIDE GROUP

21stCentury.jfif

21ST CENTURY

Image by Mikita Yo

INVESTORS

Morningside-Main-logo-002.jpg

MORNINGSIDE VENTURES

paa_logo4x3.jpg

PRINCETON ALUMNI ANGELS

CatalyticImpactFoundation_logo.jpg

CATALYTIC IMPACT FOUNDATION

Next Wave Bio.png

NEXT WAVE BIO

ANY Seed Fund.png

ACCELERATE NEW YORK SEED FUND

bottom of page